Seroprevalence of anti-SARS-CoV-2 antibodies in Iquitos, Loreto, Peru

Carlos Álvarez-Antonio, Graciela Meza-Sánchez, Carlos Calampa, Wilma Casanova, Cristiam Carey, Freddy Alava, Hugo Rodríguez-Ferrucci, Antonio M. Quispe
doi: https://doi.org/10.1101/2021.01.17.21249913

Article Information

doi 
https://doi.org/10.1101/2021.01.17.21249913
History 
  • January 20, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.

Author Information

  1. Carlos Álvarez-Antonio1,
  2. Graciela Meza-Sánchez1,2,
  3. Carlos Calampa1,2,
  4. Wilma Casanova2,
  5. Cristiam Carey2,
  6. Freddy Alava1,
  7. Hugo Rodríguez-Ferrucci2 and
  8. Antonio M. Quispe3,4,*
  1. 1Dirección Regional de Salud de Loreto, DIRESA, Loreto, Peru
  2. 2Universidad Nacional de la Amazonía Peruana, Loreto, Peru
  3. 3Centro de Investigación en Bioingeniería, Universidad de Ingeniería y Tecnología, Lima, Peru
  4. 4Universidad Continental, Huancayo, Peru
  1. ↵*Corresponding Author
    Antonio M. Quispe MD, MSc, CPH, PhD, Centro de Investigación en Bioingeniería, Universidad de Ingeniería y Tecnología, Lima, Peru & Universidad Continental, Huancayo, Peru, Addreess: General Borgoño 355, Miraflores Email: aquispeg{at}utec.edu.pe, Phone: +51-96216-9510
Back to top
Posted January 20, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Seroprevalence of anti-SARS-CoV-2 antibodies in Iquitos, Loreto, Peru
Carlos Álvarez-Antonio, Graciela Meza-Sánchez, Carlos Calampa, Wilma Casanova, Cristiam Carey, Freddy Alava, Hugo Rodríguez-Ferrucci, Antonio M. Quispe
medRxiv 2021.01.17.21249913; doi: https://doi.org/10.1101/2021.01.17.21249913
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area